Induction of senescence‐associated growth inhibitors in the tumor‐suppressive function of retinoids
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Retinoids, physiological regulators of cell growth and differentiation, are used in the treatment or chemoprevention of several malignant diseases. This class of compounds can induce growth arrest or apoptosis in tumor cells. Permanent growth arrest of retinoid‐treated cells is often assumed to result from retinoid‐induced differentiation. Recent studies in breast carcinoma and neuroblastoma cells demonstrated that retinoids can stop tumor cell growth through the program of senescence rather than differentiation. Retinoid‐induced tumor suppression is associated with the induction of multiple intracellular and secreted growth‐inhibitory proteins. Most of these proteins were also found to be upregulated in senescent cells. The induction of senescence‐associated growth inhibitors appears to be an indirect effect of retinoids. Elucidation of the mechanisms responsible for the induction of growth‐inhibitory genes in retinoid‐treated cells should help in developing agents that would mimic the antiproliferative effect of retinoids in retinoid‐insensitive cancers. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“This ‘‘accelerated senescence’’ is triggered by such factors as DNA damage or expression of mutant Ras [Di Leonardo et al., 1994; Serrano et al., 1997; Robles and Adami, 1998].”
BackgroundA Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · cited 1×
“Continuous p16 expression is believed to be responsible for the maintenance of growth arrest in normal senescent cells [Alcorta et al., 1996; Stein et al., 1999].”
BackgroundStein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868
Andrews, P. W. (1984) · Developmental Biology · doi:10.1016/0012-1606(84)90316-6 · Cited by 806
The promise of retinoids to fight against cancer
Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773 · cited 6×
“Retinoids are also routinely used in several premalignant diseases, including leukoplakia, actinic keratosis, and cervical dysplasia, and in chemoprevention of skin cancer in patients with xeroderma pigmentosum [Altucci and Gronemeyer, 2001].”
BackgroundInfluentialRobles, S. J., & Adami, G. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201862 · Cited by 498
Chang, B.-D., Watanabe, K., Broude, E. V., Fang, J., Poole, J. C., Kalinichenko, T. V., & Roninson, I. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4291 · Cited by 432 · cited 1×
“…fac- tors is mediated in part through p21, and p21 expression alone is sufficient to induce such genes and their associated paracrine activities [Chang et al., 2000]. p21 induction is a common response to DNA-damaging agents and some other chemotherapeutic drugs, and the side effects of p21…”
BackgroundSelf-citationTumor suppressors and oncogenes in cellular senescence
Bringold, F., & Serrano, M. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00083-8 · Cited by 379
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312
Self-citation
Cited by
(2003) · PubMed · Cited by 608
Cell cycle arrest is not senescence
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100281 · Cited by 217
“Senescent cells secrete both mitogenic and anti-mitogenic factors [16-27].”
BackgroundChinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R. ‐., Campisi, J., & Andersen, J. K. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12029 · Cited by 165
“Many DNA-damaging chemotherapies as well as radiotherapy can, for example, induce senescence [23, 24].”
ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein
Boulay, P.-L., Schlienger, S., Lewis-Saravalli, S., Vitale, N., Ferbeyre, G., & Claing, A. (2011) · Oncogene · doi:10.1038/onc.2011.100 · Cited by 61
Zhang, Y., Li, P., Pan, H., Liu, L., Ji, M., Sheng, N., Wang, C., Cai, L., & Ma, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.023 · Cited by 56
Metadata
- Authors
- Roninson, I. B., & Dokmanovic, M.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2002-10-31
- Volume
- 88
- Issue
- 1
- Pages
- 83-94
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2031214816
- Cited by
- 44
- References
- 11
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Induction of senescence‐associated growth inhibitors in the tumor‐suppressive function of retinoids. https://app.cochat.ai/papers/10.1002/jcb.10320
- The paper
- Roninson, I. B., & Dokmanovic, M. (2003). Induction of senescence‐associated growth inhibitors in the tumor‐suppressive function of retinoids. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.10320
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.